European scientists believe they have an explanation for the blood clots reported in a tiny number of people who received Oxford-AstraZeneca's coronavirus vaccine. Patients who endured the brain clot were likely to suffer severe headaches, dizziness and loss of vision in the days after being vaccinated. These samples were then compared to 20 individuals who were given the AstraZeneca vaccine and did not experience blood clots. The country's National Advisory Committee on Immunization is recommended the pause, citing lingering worries over rare blood clots, and Health Canada officially called for the suspension on Monday. Meanwhile, a group of researchers in Norway say have been studying three cases of blood clots post-AstraZeneca vaccination.

Source: Daily Mail March 29, 2021 23:08 UTC